These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 23538147)
1. Hemodialysis duration, human platelet antigen HPA-3 and IgA isotype of anti-β2glycoprotein I antibodies are associated with native arteriovenous fistula failure in Tunisian hemodialysis patients. Hadhri S; Rejeb MB; Belarbia A; Achour A; Skouri H Thromb Res; 2013 May; 131(5):e202-9. PubMed ID: 23538147 [TBL] [Abstract][Full Text] [Related]
2. IgA antibodies against β2 glycoprotein I in hemodialysis patients are an independent risk factor for mortality. Serrano A; García F; Serrano M; Ramírez E; Alfaro FJ; Lora D; de la Cámara AG; Paz-Artal E; Praga M; Morales JM Kidney Int; 2012 Jun; 81(12):1239-44. PubMed ID: 22358146 [TBL] [Abstract][Full Text] [Related]
3. A prospective study of the prevalence of heparin-induced antibodies and other associated thromboembolic risk factors in pediatric patients undergoing hemodialysis. Skouri H; Gandouz R; Abroug S; Kraiem I; Euch H; Gargouri J; Harbi A Am J Hematol; 2006 May; 81(5):328-34. PubMed ID: 16628723 [TBL] [Abstract][Full Text] [Related]
4. Platelet glycoprotein IIb HPA-3 a/b polymorphism is associated with native arteriovenous fistula thrombosis in chronic hemodialysis patients. Wu JH; Zhang DW; Cheng XL; Shi H; Fan YP Ren Fail; 2012; 34(8):960-3. PubMed ID: 22880801 [TBL] [Abstract][Full Text] [Related]
5. Antiphospholipid Antibodies and Procoagulant Profile in Tunisians With Inflammatory Bowel Diseases. Kraiem I; Hadhri S; Ben Rejeb M; Ifa L; Jmaa A; Ajmi S; Skouri H Clin Appl Thromb Hemost; 2016 Nov; 22(8):734-742. PubMed ID: 25878173 [TBL] [Abstract][Full Text] [Related]
6. Thrombophilic risk factors and ABO blood group profile for arteriovenous access failure in end stage kidney disease patients: a single-center experience. Anapalli SR; N HD; Sarma P; Srikanth L; V SK Ren Fail; 2022 Dec; 44(1):34-42. PubMed ID: 35094650 [TBL] [Abstract][Full Text] [Related]
7. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209 [TBL] [Abstract][Full Text] [Related]
8. IgA antiphospholipid antibodies are an independent risk factor for thromboses. Shen YM; Lee R; Frenkel E; Sarode R Lupus; 2008 Nov; 17(11):996-1003. PubMed ID: 18852223 [TBL] [Abstract][Full Text] [Related]
9. Anti-beta2 glycoprotein-I antibody increases the risk of pregnancy-induced hypertension: a case-controlled study. Yamada H; Atsumi T; Amengual O; Koike T; Furuta I; Ohta K; Kobashi G J Reprod Immunol; 2010 Jan; 84(1):95-9. PubMed ID: 20004024 [TBL] [Abstract][Full Text] [Related]
10. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome. Arvieux J; Renaudineau Y; Mane I; Perraut R; Krilis SA; Youinou P Thromb Haemost; 2002 Apr; 87(4):599-605. PubMed ID: 12008941 [TBL] [Abstract][Full Text] [Related]
11. Immune Complexes of Beta-2-Glycoprotein I and IgA Antiphospholipid Antibodies Identify Patients With Elevated Risk of Thrombosis and Early Mortality After Heart Transplantation. Serrano M; Morán L; Martinez-Flores JA; Mancebo E; Pleguezuelo D; Cabrera-Marante O; Delgado J; Serrano A Front Immunol; 2019; 10():2891. PubMed ID: 31921152 [No Abstract] [Full Text] [Related]
12. Frequency of specific coagulation inhibitors and antiphospholipid antibodies in Tunisian haemophiliacs. Kraiem I; Hadhri S; El Omri H; Sassi R; Chaabani W; Ennabli S; Skouri H Ann Biol Clin (Paris); 2012; 70(6):659-65. PubMed ID: 23207810 [TBL] [Abstract][Full Text] [Related]
13. The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysis. Carrier M; Knoll GA; Kovacs MJ; Moore JC; Fergusson D; Rodger MA Thromb Res; 2007; 120(2):215-20. PubMed ID: 17098277 [TBL] [Abstract][Full Text] [Related]
14. Anti-beta 2-glycoprotein I antibodies of IgM class are linked to thrombotic disorders in young women without autoimmune disease. Salobir B; Sabovic M; Hojnik M; Cucnik S; Kveder T Immunobiology; 2007; 212(3):193-9. PubMed ID: 17412286 [TBL] [Abstract][Full Text] [Related]
15. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus. Danowski A; Kickler TS; Petri M J Rheumatol; 2006 Sep; 33(9):1775-9. PubMed ID: 16960938 [TBL] [Abstract][Full Text] [Related]
16. Prospective study on autoantibodies against apolipoprotein H (beta2GPI) in several clinical parameters from patients with terminal renal failure and functioning renal transplants. Ramírez E; Serrano A; García F; Alfaro FJ; Pérez V; Paz-Artal E; Morales JM Transplant Proc; 2009; 41(6):2370-2. PubMed ID: 19715922 [TBL] [Abstract][Full Text] [Related]
17. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome. Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748 [TBL] [Abstract][Full Text] [Related]
18. Antibodies to beta2-glycoprotein I and annexin V in women with early and late idiopathic recurrent spontaneous abortions. Zammiti W; Mtiraoui N; Hidar S; Fekih M; Almawi WY; Mahjoub T Arch Gynecol Obstet; 2006 Aug; 274(5):261-5. PubMed ID: 16826414 [TBL] [Abstract][Full Text] [Related]
19. Human platelet antigens polymorphisms and susceptibility of thrombosis in hemodialysis patients. Gorgi Y; Sfar I; Ben Aabdallah T; Aouadi H; Abderrahim E; Bardi R; Jendoubi-Ayed S; Ayed K Hemodial Int; 2008 Jul; 12(3):331-5. PubMed ID: 18638089 [TBL] [Abstract][Full Text] [Related]
20. Arteriovenous fistula thrombosis in patients on regular hemodialysis: a report of 171 patients. Roozbeh J; Serati AR; Malekhoseini SA Arch Iran Med; 2006 Jan; 9(1):26-32. PubMed ID: 16649374 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]